Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
974.5 INR | +0.05% | -4.09% | +20.11% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.11% | 2.09B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend